IL10 and autoimmune disease: In a study by Lavasani et al., a novel probiotic mixture shows significant therapeutic potential in ameliorating experimental autoimmune encephalomyelitis (EAE), primarily through the induction of IL-10-producing regulatory T cells, which underscores the immunomodulatory effects of probiotics in autoimmune disorders [175].